NASDAQ: CHRS
Coherus Oncology Inc Stock Ownership - Who owns Coherus Oncology?

Insider buying vs selling

Have Coherus Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis M. LanfearPresident CEO2026-01-2011,839$1.55
$18.35kSell
Bryan J. McMichaelChief Financial Officer2026-01-201,715$1.55
$2.66kSell

1 of 1

CHRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CHRS insiders and whales buy or sell their stock.

CHRS Shareholders

What type of owners hold Coherus Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vsciences Investments Pte Ltd4.78%7,381,116$3.53MInsider
Lilly Co Eli1.97%3,042,019$1.45MInsider
Dennis M. Lanfear1.89%2,926,612$1.40MInsider
Daiichi Sankyo Company Ltd1.86%2,867,426$1.37MInsider
Kkr Biosimilar LP1.62%2,499,499$1.19MInsider
Fmr LLC0.82%1,272,504$608.26kInsider
Alan C. Herman0.23%350,624$167.60kInsider
August J. Troendle0.19%298,422$142.65kInsider
Bryan J. McMichael0.09%133,736$63.93kInsider
Vincent R. Anicetti0.08%124,790$59.65kInsider

1 of 3

CHRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CHRS0.04%14.00%Net Selling
TNYA0.02%36.40%Net Selling
COYA0.03%9.20%
CLLS0.00%0.00%
CING0.02%29.24%Net Buying

Coherus Oncology Stock Ownership FAQ

Who owns Coherus Oncology?

Coherus Oncology (NASDAQ: CHRS) is owned by 0.04% institutional shareholders, 14.00% Coherus Oncology insiders, and 85.96% retail investors. Vsciences Investments Pte Ltd is the largest individual Coherus Oncology shareholder, owning 7.38M shares representing 4.78% of the company. Vsciences Investments Pte Ltd's Coherus Oncology shares are currently valued at $3.53M.

If you're new to stock investing, here's how to buy Coherus Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.